Verve Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
VERV
CUSIP
92539P101
Type
Equity
Class
COM
Num filers
168
Total reported value, excl. options
$372M
Manager Report Date Value ($000) Shares